titanium implants
08.08.2013
News
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]
21.07.2015
Juvéderm® VOLIFT™ Retouch extends the VYCROSS™ Collection
Allergan Symposium at the 13. AMWC in Monaco: The day long symposium under the guidance of Dr. Koenraad de Boulle from Belgium was dedicated to the motto „Achieving real expressions […]
13.07.2016
Cynosure to Ring NASDAQ Stock Market Closing Bell to Celebrate 25 Year Anniversary
Cynosure, Inc. (NASDAQ: CYNO) today announced that President and CEO Michael Davin, along with other members of the Company’s management team, will ring the Closing Bell at the NASDAQ Stock […]